Cefazolin in Dextrose Injection shortage
To Be Discontinued 3 presentations · 1 manufacturers · first FDA posting Oct 30, 2026 · last update Oct 30, 2026
Availability: Not stated 3
Manufacturers: Baxter Healthcare
Stated reasons (per FDA): Not stated (FDA did not give a reason)
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Availability | FDA dates |
|---|---|---|
| Cefazolin in Dextrose, Injection, 1g/50 mL (NDC 0338-3503-41) Baxter Healthcare FDA note: Discontinuation of the manufacture of the drug | Not stated To Be Discontinued | Updated Oct 30, 2026 First posted Oct 30, 2026 Discontinued Oct 30, 2026 |
| Cefazolin in Dextrose, Injection, 2g/100mL (NDC 0338-3508-41) Baxter Healthcare FDA note: Discontinuation of the manufacture of the drug | Not stated To Be Discontinued | Updated Oct 30, 2026 First posted Oct 30, 2026 Discontinued Oct 30, 2026 |
| Cefazolin in Dextrose, Injection, 3g/150mL (NDC 0338-0096-06) Baxter Healthcare FDA note: Discontinuation of the manufacture of the drug | Not stated To Be Discontinued | Updated Oct 30, 2026 First posted Oct 30, 2026 Discontinued Oct 30, 2026 |